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SURGICALTECHNIQUESUsefulness of bridging thoracic endovascular aortic repair and sac
irrigation followed by open repair in patients with mycotic thoracic
aortic aneurysmsHideki Oshima, MD, PhD,a Kiyohito Yamamoto, MD, PhD,b Kimihiro Komori, MD, PhD,b and
Akihiko Usui, MD, PhD,a Nagoya, JapanMycotic thoracic aortic aneurysms are serious disorders,
and the operative mortality is significantly high as a result
of instability of the patient’s condition related to sepsis.1
We successfully treated 2 such patients with thoracic endo-
vascular aortic repair (TEVAR) as a bridge to a safer open
reconstruction procedure.FIGURE 1. A, Computed tomographic scans showed a mycotic aneurysm of th
axial image; lower row, 3-dimensional reconstruction). B, Computed tomograph
shielding of the aneurysm (upper row, axial image, lower row, 3-dimensional rec
arch was completely shielded by the stent graft (arrow). D, A computed tomogr
distal aortic arch and left subclavian artery. Asc. Ao, Ascending aorta.
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Patient 1
A 70-year-old woman was referred to our hospital with
chest pain. She was in a state of sepsis, as documented by
a high-grade fever and arterial hypoxemia. The C-reactive
protein level was 24.9 mg/dL, and computed tomography
showed a large aortic arch aneurysm (Figure 1, A).
Although no bacteria were detected in a blood culture, a
mycotic aneurysm was diagnosed on the basis of both the
patient’s clinical and the imaging findings. To prevent
rupture and to stabilize the patient’s ill state, we performed
emergency TEVAR as a bridge to a second-stage open pro-
cedure. A 40 3 150-mm GORE TAG device (W. L. Gore
and Associates, Flagstaff, Ariz) was implanted (Figure 1,
B), followed by the administration of ceftriaxone sodium
(INN ceftriaxone) and clindamycin. Eight days after TE-
VAR, open surgery was performed through an upper-halfe aortic arch (arrow) before thoracic endovascular aortic repair (upper row,
ic scans obtained after thoracic endovascular aortic repair showed complete
onstruction). C, Intraoperative findings. The mycotic aneurysm in the aortic
aphic scan obtained after open surgery showed in situ reconstruction of the
gery c November 2014
FIGURE 2. A, A computed tomographic scan with curved multiplanar reconstruction obtained before thoracic endovascular aortic repair showed a large
mycotic aneurysm in the aortic arch. B, A computed tomographic scan obtained after thoracic endovascular aortic repair showed no leakage into the aneu-
rysmal cavity. C, Four days after thoracic endovascular aortic repair, percutaneous drainage of the aneurysmal cavity was performed under computed tomo-
graphic guidance. D and E, Intraoperative findings. D, The mycotic aneurysm in the aortic arch (arrowhead). E, The aneurysm was completely shielded by
the stent graft (arrow). The purple-colored tissue (arrowhead) indicates gentian violet staining. BCA, Brachiocephalic artery; Asc. Ao, ascending aorta.
Surgical Techniquessternotomy with left anterior thoracotomy. Before the initi-
ation of cardiopulmonary bypass, the aneurysm was opened
and the infected tissue was excised under a bloodless field
created by the shielding effect of TEVAR (Figure 1, C).
An emergency bacterial test detected Staphylococcus
aureus in the infected tissue. After establishment of moder-
ate hypothermic circulatory arrest and selective cerebral
perfusion, the stent graft was explanted and in situ aortic
arch reconstruction with a rifampicin-bonded prosthetic
graft was performed (Figure 1, D). Finally, the entire graft
was covered with an omental pedicle.2 The patient has sur-
vived for 1 year since the operation.
Patient 2
A 64-year-old man was admitted with a high-grade
fever. His C-reactive protein level was 27.5 mg/dL, and
methicillin-resistant S aureuswas detected in a blood culture.
Computed tomography demonstrated a large aneurysm in the
distal arch (Figure 2, A), and the patient’s condition wasThe Journal of Thoracic and Cardiagnosed as mycotic aneurysm. He was too sick to tolerate
open surgery. Emergency TEVAR (Figure 2, B) was
performed with a 36 3 152-mm Zenith TX2 device (Cook
Medical Inc, Bloomington, Ind). Despite the administration
of sufficient vancomycin, the patient’s fever continued.
Four days after TEVAR, percutaneous drainage of the aneu-
rysmal cavity with an 8F Ureflex Mini-Pigtail Drainage
Catheter (UreSil, LLC, Skokie, Ill) was performed under
computed tomographic guidance (Figure 2, C), and daily
irrigation with 0.02% gentian violet solution was initiated.3
The irrigation was performed once a day according to our
protocol as follows: (1) First 5 mL of 0.02% gentian violet
solution was injected into the cavity through a drainage
tube with a syringe, and then suction was immediately
applied it to remove the solution. (2) This procedure was
repeated 10 times. (3) Finally, 5 mL of 0.02% gentian violet
solution was injected, followed by open drainage. The
C-reactive protein level finally decreased to 3.5 mg/dL, and
we performed open arch reconstruction through a partialdiovascular Surgery c Volume 148, Number 5 2423
Surgical Techniquessternotomy with left thoracotomy 19 days after TEVAR. The
patient has survived for 10 months since the operation
without any adverse events.
DISCUSSION
Recently, TEVAR has been applied to treat mycotic
aortic aneurysms to minimize the invasiveness of open sur-
gery, although placement of an endovascular graft in an in-
fected environment remains controversial.4 When the
infection persists after TEVAR, it is likely to lead to a sub-
sequent irremediable disaster. In such conditions, adjunct
procedures are necessary to eliminate the source of infec-
tion, and percutaneous drainage of an infected aneurysmal
sac is suggested as one of several potentially useful
interventions.
For high-risk patients, we propose the temporary use of
TEVAR,5 with or without the irrigation of the infected aneu-
rysmal sac, before open surgery, thus stabilizing the infec-
tion and allowing for a safer open reconstruction. In the
case of patient 2, we administered daily irrigation with
gentian violet solution through a drainage tube to help ster-
ilize the infected bed. The shielding offered by TEVAR al-
lowed us to insert a drainage tube safely into the infected
aneurysmal cavity; this method is certainly novel.
Gentian violet, a triphenylmethane dye, has a bactericidal
effect against Candida species, streptococci, and staphylo-
cocci (including methicillin-resistant S aureus). It is alsoFrom the Department of Adult Cardiac Surgery,a Fondazione Toscana G. Monasterio,
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Gentian violet has been used to treat skin infections, and
its application in the setting of prosthetic graft infection
was recently reported.3
The use of bridging TEVAR allowed us to effect an
improvement in the patient’s condition and to perform
the necessary drainage and irrigation of the aneurysmal
sac before open surgery. We therefore believe that a combi-
nation of bridging TEVAR and aneurysmal sac irrigation is
a superior alternative strategy for treating critically ill pa-
tients with mycotic thoracic aortic aneurysms relative to
the use of either single-stage open surgery or TEVAR
alone.
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a right minithoracotomyAntonio Lio, MD,a Michele Murzi, MD,a Marco Solinas, MD,a and Mattia Glauber, MD,b Massa and
Milan, ItalyTriple valve surgery (TVS) is still a challenge for surgeons
owing to the prolonged cardiopulmonary bypass and
myocardial ischemic times, with a reported operativemortality of 2.5% to 25%.1 Furthermore, patients undergo-
ing TVS usually have late stage disease, making them
vulnerable during surgery. Few data are available of the
treatment of TVS with a minimally invasive approach,
although the benefits of minimally invasive cardiac surgery
have been well recognized.2 We describe our experience
with 5 patients who underwent TVS through a right
minithoracotomy, with the aim of demonstrating the
technical feasibility of this type of surgery.
CLINICAL SUMMARY
From September 2008 to November 2012, 5 patients
were scheduled for TVS through a right minithoracotomy
at our institution. The 5 patients were all women (100%),gery c November 2014
